Aetna policies, page 98

Search Aetna's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Aetna, by title.

Aetna policies
PolicyDetailsCodesSource
Fundus Photography0539 · Commercial13Original policy ↗
Gabapentin IR Limit, Post PA 2970-HJ P06-2025 v22970-HJ P06-2025 v2 · Commercial—Original policy ↗
Gastroesophageal Reflux Disease (GERD)0213 · Commercial26Original policy ↗
Gastrointestinal Function: Selected Tests0396 · Commercial14Original policy ↗
Gastrointestinal Manometry0616 · Commercial10Original policy ↗
Gattex 1838-A SGM P20221838-A · Commercial—Original policy ↗
Gattex SGM 1838-A P20261838-A P2026 · Commercial—Original policy ↗
Gemcitabine Intravesical System (Inlexzo)1095 · Commercial6Original policy ↗
Gender Affirming Surgery0615 · Commercial210Original policy ↗
Gene-Based Therapy for Duchenne Muscular Dystrophy (DMD)0911 · Commercial17Original policy ↗
Genetic Testing0140 · Commercial227Original policy ↗
Gentamicin Topical Limit, Post PA Policy 4214-HJ 03-20224214-HJ · Commercial—Original policy ↗
Gilenya-Tascenso ODT 1842-A SGM P2022a1842-A · Commercial—Original policy ↗
Gilotrif 1658-A SGM P20241658-A · Commercial—Original policy ↗
Glaucoma Surgery0484 · Commercial65Original policy ↗
Glaucoma Testing0622 · Commercial18Original policy ↗
GLP-1 Agonist Ozempic PA with Limit Policy 2439-C 08-2022 v22439-C · Commercial—Original policy ↗
GLP-1 Agonist Rybelsus PA with Limit Policy 3318-C UDR 05-20233318-C · Commercial—Original policy ↗
GLP-1 Agonist Trulicity PA with Limit 1193-C 08-20221193-C · Commercial—Original policy ↗
GLP-1 Agonist Victoza PA with Limit Policy 479-C UDR 05-2023479-C · Commercial—Original policy ↗
Golimumab (Simponi and Simponi Aria)0790 · Commercial74Original policy ↗
Gonadotropin-Releasing Hormone Analogs and Antagonists0501 · Commercial29Original policy ↗
Gralise, Horizant Limit 3911-H P06-2024_R3911-H P06-2024_R · Commercial—Original policy ↗
Gralise, Horizant Limit Policy 3911-H 06-20233911-H · Commercial—Original policy ↗
Growth Hormone (GH) and Growth Hormone Antagonists0170 · Commercial52Original policy ↗
Haegarda 2100-A SGM P20222100-A · Commercial—Original policy ↗
Haegarda 2100-A SGM P20232100-A · Commercial—Original policy ↗
Haegarda SGM 2100-A P2024b_R2100-A · Commercial—Original policy ↗
Haegarda SGM 2100-A P2024b_R2100-A · Commercial—Original policy ↗
Hammertoe Repair0636 · Commercial26Original policy ↗
hCG 1925-A, 1926-A SGM P20211925-A, 1926-A · Commercial—Original policy ↗
Headaches: Invasive Procedures0707 · Commercial143Original policy ↗
Headaches: Nonsurgical Management0462 · Commercial50Original policy ↗
Hearing Aids0612 · Commercial22Original policy ↗
Heart Transplantation0586 · Commercial30Original policy ↗
Heart-Lung Transplantation0597 · Commercial6Original policy ↗
Heating Devices0540 · Commercial21Original policy ↗
Helicobacter Pylori Infection Testing0177 · Commercial15Original policy ↗
Hematopoietic Cell Transplantation for Aplastic Anemia and other Bone Marrow Failure Syndromes0627 · Commercial36Original policy ↗
Hematopoietic Cell Transplantation for Autoimmune Diseases and Miscellaneous Indications0606 · Commercial19Original policy ↗
Hematopoietic Cell Transplantation for Breast Cancer0507 · Commercial5Original policy ↗
Hematopoietic Cell Transplantation for Hodgkin's Disease0495 · Commercial23Original policy ↗
Hematopoietic Cell Transplantation for Multiple Myeloma0497 · Commercial21Original policy ↗
Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma0494 · Commercial16Original policy ↗
Hematopoietic Cell Transplantation for Ovarian Cancer0635 · Commercial9Original policy ↗
Hematopoietic Cell Transplantation for Selected Childhood Solid Tumors0496 · Commercial25Original policy ↗
Hematopoietic Cell Transplantation for Selected Leukemias0640 · Commercial17Original policy ↗
Hematopoietic Cell Transplantation for Testicular Cancer0617 · Commercial8Original policy ↗
Hematopoietic Cell Transplantation for Thalassemia Major and Sickle Cell Anemia0626 · Commercial27Original policy ↗
Hematopoietic Cell Transplantation for Waldenstrom Macroglobulinemia0833 · Commercial5Original policy ↗

Back to Aetna · Aetna prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.